MedTrace Logo

Resistant Starch, Antioxidant Status and Insulin Resistance

NCT01992783 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2015-08-18

No results posted yet for this study

Summary

The aim of this study is to evaluate whether supplementation with resistant starch improves biomarkers associated with antioxidant status and insulin resistance in subjects with overweight and obesity.

Conditions

Interventions

DIETARY_SUPPLEMENT

Hi-maize resistant starch

13.5 g/day

DIETARY_SUPPLEMENT

Maltodextrin

13.5 g/day

Sponsors & Collaborators

  • Urmia University of Medical Sciences

    lead OTHER

Principal Investigators

  • Mohammad Alizadeh, PhD · Assistant Professor in Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-11-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01992783 on ClinicalTrials.gov